ED 09. Safety and efficacy of tadalafil 5 mg administered once daily in men with erectile dysfunction and lower urinary tract symptoms
Erectile Dysfunction

ED 09. Safety and efficacy of tadalafil 5 mg administered once daily in men with erectile dysfunction and lower urinary tract symptoms

Sungwoo Hong, Tai Young Ahn

Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea


Objectives: Recent data suggest that there may be an association between erectile dysfunction (ED) and lower urinary tract symptoms (LUTS). Increasing evidence also indicates that the clinical use of phosphodiesterase type 5 (PDE5) inhibitors provides relief from LUTS. The purpose of our study is to investigate the safety and effects of Tadalafil 5 mg once daily in men with ED and LUTS.

Design and Methods: This study included a total of 89 patients who complained of ED and LUTS and who were given tadalafil 5 mg once daily for eight weeks between September 2009 and February 2011. The International Prostate Symptom Score (IPSS) and the International Index of Erectile Function (IIEF)- 5 questionnaire information were obtained prior to treatment (V1), and again following treatment with Tadalafil 5 mg once a day (weeks 4 (V2) and 12 (V3) after treatment began). We also evaluated any adverse effects of Tadalafil 5 mg when it was administered once daily during the follow-up period.

Results: A total, of 60 patients (67.4%) completed the eightweek clinical study. The mean patient age was 57.0±9.2 years. Regarding subjective symptoms, there were 48 patients (80.0%) who experienced improvement of their ED and 43 patients (71.7%) who experienced the improvement of their LUTS. The IPSS values were 15.33±8.32 (V1), 11.78±7.69 (V2), and 9.91±7.77 (V3), with significant improvement (V1 vs. V2, P=0.042, V1 vs. V3, P=0.006). The IIEF-5 values were 8.34±5.33 (V1), 15.74±8.99 (V2), and 18.72±19.58 (V3), with significant improvement (V1 vs. V2, P=0.001, V1 vs. V3, P=0.001). A total of three patients (5.0%) reported adverse effects, i.e. two patients experienced facial flushing and one patient had mild chest discomfort.

Conclusions: Treatment with Tadalafil 5 mg once daily was beneficial for the treatment of both ED and LUTS. Adverse effects on the cardiovascular system were minimal in our study. Therefore, we believe that taking Tadalafil 5 mg once daily is safe for patients with ED and LUTS.

Key words

Erectile dysfunction; tadalafil; lower urinary tract symptoms

DOI: 10.3978/j.issn.2223-4683.2012.s073

Article Options

Download Citation